Hallux ValgusNCT06874517
Second Toe Length and Hallux Valgus: Greek vs. Egyptian Foot
An observational study of Hallux Valgus, run by Beylikduzu State Hospital at 1 site in Turkey (Türkiye).
Trial summary
A total of 150 patients aged 60-80 years with existing foot radiographs will be included in the study. Radiographic evaluations will include measurements of the hallux valgus angle, first intermetatarsal angle, and the metatarsal and phalanx lengths of the first and second toes. Read more about this study
- Who is it for?
- Ages 60 to 80 years
- Conditions the study is for
- Hallux Valgus
- How many people
- 150 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 10 Mar 2025to 10 Apr 2025
- How long will I take part?
- 1 Day
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 60 to 80 years
- All sexes
- Adult, Older adult
Study population: The study population will consist of 150 patients aged 60-80 years who have existing foot radiographs suitable for measurement.
Who may be able to join
- Age between 60-80 years
- Presence of foot radiographs suitable for measurement
- No history of prior foot surgery
Who cannot join
- History of foot trauma or fractures
- Previous foot or toe surgery
- Presence of congenital foot deformities
- Neurological or rheumatologic conditions affecting foot structure
- Severe osteoarthritis or other degenerative foot diseases visible on radiographs
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Turkey (Türkiye)1 site, 1 recruiting
- Recruiting
Beylikdüzü State Hospital
Istanbul, Beylikdüzü, 34147
Büşra Şirin, 02124443322, bsrn080@gmail.com
Büşra Şirin Ahısha, MD
About this study
Official title: Greek vs. Egyptian Foot: The Impact of Second Toe Length on Hallux Valgus Development
A total of 150 patients aged 60-80 years with existing foot radiographs will be included in the study. Radiographic evaluations will include measurements of the hallux valgus angle, first intermetatarsal angle, and the metatarsal and phalanx lengths of the first and second toes. The ratio of the second toe phalanx length to the first toe phalanx length will be calculated and recorded. The relationship between the hallux valgus angle, toe lengths, and their ratios will be analyzed using statistical methods.
- Conditions
- Hallux Valgus
- Being tested
- no intervention
- Medical subject headings
- Hallux Valgus
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
no interventionOther
no intervention
What is being measured
The primary outcome is the main question the study is designed to answer.
Hallux Valgus Angle
The angle between the first metatarsal and the proximal phalanx of the first toe, measured on radiographs. Higher values indicate greater hallux valgus severity.
Measured: 0 day
Secondary outcomes (4)
First Intermetatarsal Angle
The angle between the first and second metatarsal bones, measured on radiographs. Higher values are associated with increased deformity.
Measured: 0 day
First Toe (Hallux) Metatarsal and Phalanx Lengths
The length of the first metatarsal and its phalanges, measured on radiographs.
Measured: 0 day
Second Toe Metatarsal and Phalanx Lengths
The length of the second metatarsal and its phalanges, measured on radiographs.
Measured: 0 day
Second Toe to First Toe Phalanx Length Ratio
The ratio of the second toe phalanx length to the first toe phalanx length, calculated to assess relative toe length differences.
Measured: 0 day
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 Mar 2025
- Study start10 Mar 2025
- Primary completion10 Apr 2025 (estimated)
- Study completion10 Apr 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Hallux ValgusStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Enrolment
- 150 participants (estimated)
- Target duration
- 1 Day
Sponsor and investigators
- Lead sponsor
- Beylikduzu State Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Busra Sirin, Beylikduzu State Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06874517
- Sponsor's protocol ID
- BeylikduzuStateH15
- Status last verified
- Mar 2025
- First submitted
- 8 Mar 2025
- Last updated
- 26 Mar 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 26 Mar 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Greek vs. Egyptian Foot: The Impact of Second Toe Length on Hallux Valgus Development
- ClinicalTrials.gov ID
- NCT06874517
- Acronym / sponsor ID
- BeylikduzuStateH15
- Conditions
- Hallux Valgus
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 150 participants (estimated)
- Lead sponsor
- Beylikduzu State HospitalUniversity, hospital or other
- Study start
- 10 Mar 2025 (actual)
- Primary completion
- 10 Apr 2025 (estimated)
- Study completion
- 10 Apr 2025 (estimated)
- First posted
- 13 Mar 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
A total of 150 patients aged 60-80 years with existing foot radiographs will be included in the study. Radiographic evaluations will include measurements of the hallux valgus angle, first intermetatarsal angle, and the metatarsal and phalanx lengths of the first and second toes. The ratio of the second toe phalanx length to the first toe phalanx length will be calculated and recorded. The relationship between the hallux valgus angle, toe lengths, and their ratios will be analyzed using statistical methods.
Study design
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Target follow-up
- 1 Day
Who may qualify
- Ages
- 60 to 80 years
- Sex
- All
- Age groups
- Adult, Older adult
- Study population
- The study population will consist of 150 patients aged 60-80 years who have existing foot radiographs suitable for measurement.
Key inclusion criteria (3 listed)
- Age between 60-80 years
- Presence of foot radiographs suitable for measurement
- No history of prior foot surgery
Key exclusion criteria (5 listed)
- History of foot trauma or fractures
- Previous foot or toe surgery
- Presence of congenital foot deformities
- Neurological or rheumatologic conditions affecting foot structure
- Severe osteoarthritis or other degenerative foot diseases visible on radiographs
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| no interventionno intervention | Other | – |
Primary outcome
Hallux Valgus Angle
Time frame: 0 day
The angle between the first metatarsal and the proximal phalanx of the first toe, measured on radiographs. Higher values indicate greater hallux valgus severity.
4 secondary outcomes
First Intermetatarsal Angle
Time frame: 0 day
First Toe (Hallux) Metatarsal and Phalanx Lengths
Time frame: 0 day
Second Toe Metatarsal and Phalanx Lengths
Time frame: 0 day
Second Toe to First Toe Phalanx Length Ratio
Time frame: 0 day
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 26 Mar 2025.
- Individual participant dataSharing planned: No
Related trials for Hallux Valgus
Active, not recruitingPhase 2/3
A Study of Andecaliximab in Participants With Fibrodysplasia Ossificans Progressiva (FOP)
Fibrodysplasia Ossificans Progressiva
RecruitingObservational study
A Study of VIRTUGUIDE System and DePuy Synthes Lapidus Implant in Participants Undergoing Lapidus Procedure
Hallux Valgus
Active, not recruiting
The Hyalex MTP Study
Hallux Valgus, Hallux Limitus
Not yet recruitingObservational study
Incidence and Risk Factors of Postoperative Chronic Pain in Patients Who Have Undergone Hallux Valgus Surgery
Postoperative Chronic Pain, Hallux Valgus Surgery
Recruiting
A Study to Compare Early and Partial Weight-bearing After Hallux Valgus Surgery
Hallux Valgus, Orthopedic Disorder
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Hallux Valgus, run by Beylikduzu State Hospital at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 26 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Hallux Valgus Angle (time frame: 0 day). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Mar 2025.